Bianthrone is a photochromic compound, meaning it can reversibly change its color upon exposure to light. It exhibits a unique photochemical behavior that involves a ring closure reaction upon irradiation with UV light, forming a highly colored dihydroanthracene derivative. This reaction is reversible, and heating or exposure to visible light causes the dihydroanthracene to revert back to the bianthrone form. The photochromism of bianthrone has been extensively studied for its potential applications in optical switching, data storage, and molecular devices. Bianthrone is typically synthesized through a multi-step process starting with anthrone, a cyclic ketone derivative of anthracene. The synthesis involves reacting anthrone with a reducing agent, such as zinc dust, in the presence of a strong base, like potassium hydroxide, to form bianthrone. Research on bianthrone has focused on understanding its photochromic properties, exploring its application in various fields, and designing new photochromic molecules with improved performance.'
| ID Source | ID |
|---|---|
| PubMed CID | 67948 |
| SCHEMBL ID | 769933 |
| MeSH ID | M0261399 |
| Synonym |
|---|
| nsc89778 |
| 434-85-5 |
| dehydrodianthrone |
| 9(10h)-anthracenone, 10-(10-oxo-9(10h)-anthracenylidene)- |
| .delta.10,10'-bianthrone |
| [.delta.9,10'h)-bianthracene]-10,10'-dione |
| nsc-89778 |
| AKOS005443793 |
| c28h16o2 |
| nsc627656 |
| nsc-627656 |
| 10-(10-oxo-9-anthrylidene)anthracen-9-one |
| [9,9']bianthracenylidene-10,10'-dione |
| STK367233 |
| NCIOPEN2_009646 |
| bianthrone |
| B-2370 |
| B0827 |
| mgrrgkwpevfjsh-uhfffaoysa- |
| inchi=1/c28h16o2/c29-27-21-13-5-1-9-17(21)25(18-10-2-6-14-22(18)27)26-19-11-3-7-15-23(19)28(30)24-16-8-4-12-20(24)26/h1-16h |
| 10-(10-oxoanthracen-9-ylidene)anthracen-9-one |
| bisanthrone |
| einecs 207-106-8 |
| (delta9,9'(10h,10'h)-bianthracene)-10,10'-dione |
| 56r67p666m , |
| nsc 89778 |
| unii-56r67p666m |
| 10h,10'h-[9,9'-bianthracenylidene]-10,10'-dione |
| FT-0622945 |
| DTXSID6059994 |
| mfcd00001238 |
| SCHEMBL769933 |
| 10-(10-oxo-9(10h)-anthracenylidene)-9(10h)-anthracenone |
| phthalicaciddisodiumsalt |
| (.delta.9,9'(10h,10'h)-bianthracene)-10,10'-dione |
| MGRRGKWPEVFJSH-UHFFFAOYSA-N |
| AS-15385 |
| bainthrone |
| 9,9'-bi-9(10h)-anthracenylidene-10,1'-dione |
| Q27261425 |
| CS-0129899 |
| HY-136504 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.65) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 14 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||